IN8bio, Inc. (INAB)
1.64
+0.06
(+3.80%)
USD |
NASDAQ |
May 11, 14:50
IN8bio Total Assets (Quarterly) : 26.26M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| DiaMedica Therapeutics, Inc. | 53.08M |
| Calidi Biotherapeutics, Inc. | 8.857M |
| ACADIA Pharmaceuticals, Inc. | 1.605B |
| Alnylam Pharmaceuticals, Inc. | 5.130B |
| Amgen, Inc. | 92.50B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 3.484M |
| Shareholders Equity (Quarterly) | 22.78M |
| Debt to Equity Ratio | 0.1033 |
| Current Ratio | 10.50 |
| Net Debt Paydown Yield | 7.97% |